Perseus Proteomics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 18, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	2,672	3,311	10,849	3,951	3,504	4,892
Market Cap Growth	-48.24%	-69.48%	174.57%	12.75%	-28.37%	-
Enterprise Value	1,080	2,075	8,970	2,288	893	1,524
Last Close Price	145.00	220.00	736.00	334.00	298.00	416.00
PS Ratio	18.15	24.53	90.41	39.51	37.28	68.90
PB Ratio	2.19	2.72	7.58	2.83	1.46	1.55
P/TBV Ratio	2.19	2.72	7.58	2.83	1.46	1.55
EV/Sales Ratio	7.34	15.37	74.75	22.88	9.50	21.46
Net Debt / Equity Ratio	-1.30	-1.25	-1.16	-1.10	-1.02	-1.02
Net Debt / EBITDA Ratio	2.18	2.04	2.02	1.73	3.53	6.82
Net Debt / FCF Ratio	-	2.29	2.10	1.58	3.36	6.31
Asset Turnover	0.09	0.08	0.07	0.05	0.03	0.03
Inventory Turnover	3.81	3.17	3.56	3.71	2.33	2.50
Quick Ratio	21.00	24.11	14.02	12.69	22.47	22.02
Current Ratio	21.41	24.74	14.32	12.89	22.65	22.23
Return on Equity (ROE)	-60.07%	-54.21%	-63.89%	-58.20%	-28.33%	-28.29%
Return on Assets (ROA)	-27.52%	-27.06%	-29.41%	-26.27%	-14.85%	-13.38%
Return on Capital Employed (ROCE)	-46.00%	-47.80%	-48.80%	-57.20%	-28.40%	-15.00%
Earnings Yield	-27.87%	-21.69%	-8.33%	-27.94%	-22.43%	-12.25%
FCF Yield	-24.77%	-19.99%	-7.32%	-24.70%	-20.77%	-10.41%
Buyback Yield / Dilution	-5.10%	-4.47%	-21.05%	-0.24%	-6.94%	-57.10%